ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

MIST Milestone Pharmaceuticals Inc

1.51
0.02 (1.34%)
2024年7月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Milestone Pharmaceuticals Inc MIST NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.02 1.34% 1.51 07:56:59
始値 安値 高値 終値 前日終値
1.52 1.4819 1.52 1.51 1.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/7/1805:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/7/1805:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/7/1805:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/7/1805:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/7/1707:06EDGAR2Form SC 13D/A - General Statement of Acquisition of..
2024/7/1605:41EDGAR2Form ARS - Annual Report to Security Holders
2024/7/1605:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/7/1605:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/7/1605:34EDGAR2Form DEF 14A - Other definitive proxy statements
2024/7/1605:02EDGAR2Form 8-K - Current report
2024/5/2920:09EDGAR2Form 8-K - Current report
2024/5/2221:00GLOBEMilestone Pharmaceuticals Partners with Arrhythmia Alliance..
2024/5/1320:34EDGAR2Form 8-K - Current report
2024/5/1319:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/3/0423:00EDGAR2Form 8-K - Current report
2024/3/0206:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/2921:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
2024/2/2906:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
2024/2/2621:06EDGAR2Form 8-K - Current report
2024/2/1510:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1421:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/2622:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
2023/12/2621:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
2023/12/2621:15EDGAR2Form 8-K - Current report
2023/11/2121:00PRNCAMilestone Pharmaceuticals to Present at the Piper Sandler..
2023/11/1321:05EDGAR2Form 8-K - Current report
2023/11/1320:57PRNCAMilestone Pharmaceuticals Reports Third Quarter 2023..
2023/11/1320:37EDGAR2Form 8-K - Current report
2023/11/1320:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1200:00PRNCAMilestone Pharmaceuticals Presents Positive Results from..
2023/11/1006:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
2023/11/0723:07EDGAR2Form 8-K - Current report
2023/11/0721:00PRNUSMilestone Pharmaceuticals to Host Investor and Analyst..
2023/10/2505:05EDGAR2Form 8-K - Current report
2023/10/2420:00PRNUSMilestone Pharmaceuticals Announces Submission of New Drug..
2023/10/0620:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
2023/9/2720:00PRNUSMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
2023/9/0520:00PRNUSMilestone Pharmaceuticals to Present at the H.C. Wainwright..
2023/8/1020:40EDGAR2Form 8-K - Current report
2023/8/1020:35PRNCAMilestone Pharmaceuticals Reports Second Quarter 2023..
2023/8/1020:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

最近閲覧した銘柄

Delayed Upgrade Clock